* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Template AF presentation - New
Survey
Document related concepts
Transcript
Briefing on 4th Meeting of Antimicrobial Resistance National Focal Points Ljubljana (Slovenia), 13 March 2008 Dominique L. Monnet Senior Expert, Antimicrobial Resistance & Healthcare-Associated-Infections Scientific Advice Unit, ECDC Antimicrobial Resistance: What Does It Represent? • Several inter-related compartments of healthcare (food animals, food, general population and patients in the community, hospitals, nursing homes and long-term care facilities) • Many types of infection (bloodstream, respiratory tract, skin and soft tissue, urinary tract, surgical site, related to medical devices, etc.) • Many bacteria/microorganisms • Many antimicrobials and mechanisms of resistance • A “topic” rather than a disease Burden of HCAI and Multidrug-Resistant (MDR) Bacteria in the European Union • Approximately 3 million HCAI and 50,000 deaths attributable these infections each year in EU-25 Source: ECDC Annual Epidemiological Report 2006. • 1/4 to 1/2 of these deaths (EU-25) are due to the most common MDR bacteria, i.e. MRSA, VRE, 3GC-R E. coli/Klebsiella sp./Enterobacter sp., MDR P. aeruginosa, carbapenem-R Acinetobacter sp., in the 4 main types of HCAI: BSI, pneumonia, SSTI, UTI) D.L. Monnet, unpublished based on EARSS and other published studies • These are conservative estimates, i.e. underestimates! Antimicrobial Resistance in Europe and the ECDC • ECDC opened in May 2005 • Antimicrobial resistance (AMR) and healthcareassociated infections is one of the seven priority topics/disease area for action • Basis: Council Recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine (2002/77/EC) • One AMR National Focal Point designated by each Member States and EEA/EFTA country • Four meetings of AMR National Focal Points since 2006 • Eight country visits to discuss AMR issues based on the Council Recommendation 4th Meet. of AMR National Focal Points, Ljubljana, 13 March 2008 • 23 Member States + 1 EEA/EFTA country represented • European Commission: DG SANCO, DG RTD • Discussions on visuals, slogan and key messages for the European Antibiotic Day (toolkit for MS) • Review of the progress of Member States on two key elements of Council Recommendation (2002/77/EC): ”Intersectoral Coordination Mechanism”, i.e. national, multidisciplinary coordination group National strategy and corresponding action plan • Plans for European Antibiotic Day ”Intersectoral Coordination Mechanism” (ICM) • National, multidisciplinary coordination group to plan and coordination prevention and control of antimicrobial resistance • 19 (63%) have an ICM in place Large variation in the level of implementation and the range of activities Several countries, only implemented since the past 2-3 years • 7 countries do not have an ICM 2 had one ICM, but activity has stopped 2 are preparing their ICM • 4 countries did not report National AMR Strategy and Action Plan • Strategy for the prevention and control of AMR and a corresponding multi-year action plan (activities, timeline) • 8 (27%) have a written national strategy and/or an action plan • 18 countries do not have a written national strategy or action plan 3 countries are preparing a second action plan 1 country (only available for one region, plans to expand) 5 countries are preparing their first strategy/action plan • 4 countries did not report